
Pear Therapeutics
Founded Year
2013Stage
Asset Sale | AssetsPurchasedTotal Raised
$334.94MAbout Pear Therapeutics
Pear Therapeutics focuses on developing and commercializing software-based medicines, known as prescription digital therapeutics (PDTs), within the healthcare sector. The company offers clinically validated software-based therapeutics designed to provide better outcomes for patients, engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear Therapeutics primarily serves the healthcare industry, focusing on patients with substance use disorder, opioid use disorder, and chronic insomnia. It was founded in 2013 and is based in Boston, Massachusetts. In April 2023 Pear Therapeutics filed for bankruptcy.
Loading...
Loading...
Research containing Pear Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Pear Therapeutics in 3 CB Insights research briefs, most recently on Jan 25, 2024.

Jan 25, 2024 report
State of Digital Health 2023 ReportExpert Collections containing Pear Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pear Therapeutics is included in 3 Expert Collections, including Digital Health 50.
Digital Health 50
300 items
The most promising digital health startups transforming the healthcare industry
Digital Health
11,329 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Pear Therapeutics Patents
Pear Therapeutics has filed 14 patents.
The 3 most popular patent topics include:
- psychiatric diagnosis
- antidepressants
- cognitive behavioral therapy

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
4/11/2023 | 2/27/2024 | Data security, Monoclonal antibodies, Cryptographic hash functions, Health informatics, Medical terminology | Grant |
Application Date | 4/11/2023 |
---|---|
Grant Date | 2/27/2024 |
Title | |
Related Topics | Data security, Monoclonal antibodies, Cryptographic hash functions, Health informatics, Medical terminology |
Status | Grant |
Latest Pear Therapeutics News
Feb 22, 2025
The Business Research Company's Global Digital Insomnia Therapeutics Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034 It will grow to $4.47 billion in 2029 at a compound annual growth rate (CAGR) of 6.38%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, February 20, 2025 / EINPresswire.com / -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! The expansive global market for digital insomnia therapeutics is poised to display impressive growth trends over the next few years. From $3.27 billion in 2024, the market is projected to reach $3.49 billion in 2025, representing a compound annual growth rate CAGR of 6.64%. The increase is largely due to an increased focus on sleep disorder education, advancements in cross-platform compatibility, an emphasis on eco-friendly and sustainable digital therapeutic options, as well as a rising focus on mental health. This thriving market is projected to further expand to $4.47 billion in 2029 at a CAGR of 6.38%, fueled by technological advancements in digital health, AI and machine learning, and increased investment in sleep research. What is Driving the Growth of the Digital Insomnia Therapeutics Market? The digital insomnia therapeutics market growth is largely driven by the increasing adoption of digital health solutions. These digital platforms and technologies play a pivotal role in enhancing healthcare delivery, improving patient outcomes, and empowering individuals to manage their health effectively. This rising adoption is due to the increasing demand for accessible and cost-effective healthcare solutions, the growing prevalence of chronic diseases, heightened awareness of preventive care, and the expansion of telehealth services. Digital insomnia therapeutics, through their technology-driven solutions such as mobile apps and wearable devices, help monitor, diagnose, and manage sleep disorders. This results in better overall health outcomes and integration with broader healthcare systems. For instance, according to Rock Health, a US-based corporation, in 2022, 80% of respondents reported having used telemedicine at some point in their lives, a significant increase from 72% in 2021. Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20750&type=smp Which Companies are Pioneering the Digital Insomnia Therapeutics Market? Leading companies in the digital insomnia therapeutics market are Pear Therapeutics Inc., Zuellig Pharma Holdings Limited, Calm.com Inc., Headspace Inc., Big Health Inc., Click Therapeutics Inc., Silvercloud Health Limited, Nox Health Group Inc., OPTT Inc., Curve Health Inc., Bodymatter Inc., Sana Health Group, SleepCogni Limited, Stellar Sleep, Somnus Therapeutics Inc., SleepScore Labs, HoneyNaps USA Inc., Sliiip, Neurovalens Ltd., and WELT Corp. What are the Latest Trends in Digital Insomnia Therapeutics? In an attempt to stay ahead of the curve, major players in the digital insomnia therapeutics market are striving to develop advanced solutions like software-based mobile apps designed to offer personalized, accessible, and cost-effective treatment options for managing insomnia. In addition to sleep tracking features, these apps integrate elements such as relaxation exercises, cognitive behavioral therapy, and personalized sleep recommendations. Big Health Inc., a US-based mental health services company, for example, received United States Food and Drug Administration approval for SleepioRx in August 2024. Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/digital-insomnia-therapeutics-global-market-report How is the Digital Insomnia Therapeutics Market Segmented Globally? The digital insomnia therapeutics market has been segmented along various dimensions. By type, it includes sleep tracking apps, relaxation and meditation apps, Cognitive-Behavioral Therapy For Insomnia CBT-I, wearable devices, and other types. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels. By application, the segments are medical and household. Furthermore, sub-segments under each category provide a detailed classification like sleep tracking apps being further subdivided into basic sleep monitoring apps, advanced sleep monitoring apps, and smart alarm apps. What is the Regional Outlook for the Digital Insomnia Therapeutics Market? In 2024, North America was the largest region in the digital insomnia therapeutics market, with other key regions including Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa, also significant contributors to market revenue. Browse Through More Similar Reports By The Business Research Company Leukemia Therapeutics Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report Bipolar Disorder Therapeutics Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report Peptide Therapeutics Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report Offering detailed research and insights through 15000+ reports spanning 27 industries in 60+ geographies, The Business Research Company has built a reputation for delivering comprehensive, data-rich studies. With 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, we empower you with the information you need to stay ahead in the game. Get in touch: The Business Research Company: https://www.thebusinessresearchcompany.com/ Americas +1 3156230293 Asia +44 2071930708 Europe +44 2071930708 Email us: info@tbrc.info Stay connected: LinkedIn: https://in.linkedin.com/company/the-business-research-company YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model Oliver Guirdham The Business Research Company info@tbrc.info Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Pear Therapeutics Frequently Asked Questions (FAQ)
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
Where is Pear Therapeutics's headquarters?
Pear Therapeutics's headquarters is located at 200 State Street, Boston.
What is Pear Therapeutics's latest funding round?
Pear Therapeutics's latest funding round is Asset Sale.
How much did Pear Therapeutics raise?
Pear Therapeutics raised a total of $334.94M.
Who are the investors of Pear Therapeutics?
Investors of Pear Therapeutics include Harvest Bio, Nox Health, WELT, Click Therapeutics, SoftBank and 18 more.
Who are Pear Therapeutics's competitors?
Competitors of Pear Therapeutics include Cara Care, Click Therapeutics, Lionrock, Akili Interactive, Valera Health and 7 more.
Loading...
Compare Pear Therapeutics to Competitors

Lyra Health specializes in providing workforce mental health care solutions within the healthcare industry. The company offers evidence-based mental health care, utilizing AI-powered provider matching and a digital platform to deliver personalized support and treatment. Lyra Health's services cater to a diverse range of mental health needs, ensuring accessible and effective care for individuals and teams. It was founded in 2015 and is based in Burlingame, California.

Monument is an online platform that specializes in alcohol treatment and recovery services. The company offers a range of services, including virtual support groups, therapy, and medication management, to assist individuals in reducing or stopping alcohol consumption. Monument's treatment options are accessible online, providing a flexible and supportive environment for those seeking help with alcohol dependence. It was founded in 2018 and is based in New York, New York.

Mahana specializes in creating digital therapeutic programs for individuals with chronic health conditions within the healthcare technology sector. The company offers FDA-cleared and self-guided digital programs designed to provide physical and psychological support to patients suffering from conditions such as IBS and tinnitus. Its programs are developed in collaboration with clinicians and patients, ensuring they are empowering, personalized, and clinically tested for efficacy. The company was formerly known as Mahana Therapeutics. It was founded in 2018 and is based in San Francisco, California.

Marigold Health provides peer support for mental health and substance use recovery within the behavioral health sector. The company has a social network where individuals can engage in peer support groups, access wellness and goal-planning tools, and participate in theme-based chat groups. It serves the behavioral health and substance use recovery sectors and works with existing care teams. It was founded in 2017 and is based in Boston, Massachusetts.

DynamiCare Health is a digital platform that specializes in substance use recovery within the healthcare sector. The company offers a digital recovery platform that provides remote substance testing, recovery coaching, and financial incentives for maintaining sobriety. DynamiCare Health primarily serves individuals seeking support for addiction recovery. It was founded in 2016 and is based in Boston, Massachusetts.

BrightInsight specializes in providing a digital health platform for the biopharmaceutical and medtech sectors. The company offers solutions such as disease management, Software as a Medical Device (SaMD), and data analytics services to enhance patient care and ensure regulatory compliance. BrightInsight primarily serves life sciences companies, offering them the technology to develop, launch, and scale digital health solutions. BrightInsight was formerly known as Flex Digital Health. It was founded in 2017 and is based in San Jose, California.
Loading...